The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Expected Market Size Of The Appetite Stimulant Market From 2026 To 2030?
The appetite stimulant market has experienced substantial expansion in recent times. This market is projected to expand from $1.9 billion in 2025 to $2.06 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 8.5%. Historically, this growth can be ascribed to factors such as the widespread occurrence of malnutrition, the burden of chronic illnesses, the utilization of oncology supportive care, the increasing elderly population, and the implementation of hospital nutrition programs.
The appetite stimulant market size is anticipated to demonstrate substantial expansion in the coming years. It is projected to achieve a value of $2.86 billion by 2030, driven by a compound annual growth rate (CAGR) of 8.5%. The expansion during the forecast period can be attributed to factors such as demand for personalized nutrition, the growth of homecare treatment options, innovations in functional foods, improved appetite loss management, and enhanced chronic disease survival rates. Significant trends expected during this period include their increasing utilization in chronic disease management, a rise in adoption within geriatric nutrition, a growing inclination towards natural appetite stimulants, the broadening of functional food-based formulations, and the development of homecare nutritional support.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24149&type=smp
What Key Drivers Are Influencing The Growth Of The Appetite Stimulant Market?
An increasing number of chronic diseases is anticipated to fuel the expansion of the appetite stimulant market moving forward. A chronic disease is characterized as a long-term medical condition or illness typically lasting three months or more and often worsening over time. The growing occurrence of chronic diseases is primarily linked to inadequate diets, as unhealthy eating patterns, such as significant consumption of processed foods, sugars, and unhealthy fats, contribute to conditions like obesity, diabetes, and cardiovascular diseases. Appetite stimulants assist in managing chronic diseases by improving overall patient outcomes and nutritional status. They achieve this by boosting hunger and increasing food intake, which can help individuals gain or maintain weight. For example, in September 2023, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported that 41 million deaths globally each year, representing 74% of all fatalities, were caused by non-communicable diseases (NCDs) or chronic illnesses. Among these, 17.9 million deaths were attributed to cardiovascular diseases, 9.3 million to cancer, 4.1 million to chronic respiratory diseases, and 2.0 million to diabetes. Thus, the escalating prevalence of chronic diseases is a key driver for the growth of the appetite stimulant market.
Which Segments Are Included In The Analysis Of The Appetite Stimulant Market?
The appetite stimulant market covered in this report is segmented –
1) By Type: Prescription, Over The Counter, Natural
2) By Formulation Type: Liquid Formulations, Powder Formulations, Capsules And Tablets, Functional Foods
3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
4) By End-Users: Hospitals, Homecare, Speciality Centres
Subsegments:
1) By Prescription: Synthetic Appetite Stimulants, Cannabinoids, Corticosteroids, Antidepressants
2) By Over The Counter (OTC): Herbal Supplements, Amino Acids, Vitamins And Minerals, Probiotics
3) By Natural: Ginger, Fenugreek, Cannabis, Zinc Supplements
Which Trends Are Impacting The Growth Of The Appetite Stimulant Market?
Leading companies in the appetite stimulant market are focusing on introducing innovative items, such as ayurvedic appetite stimulants, to attract health-conscious individuals. An Ayurvedic appetite stimulant is a natural solution derived from traditional herbs that aids in increasing appetite by stimulating digestive processes, enhancing enzyme release, and improving nutrient absorption. For example, in October 2024, Lupin Limited, an India-based pharmaceutical company, announced the launch of its Aptivate Achi Bhookh Fest. This event aims to promote healthy eating habits and nutritional awareness among children through interactive activities and sessions led by specialists, with plans to expand the campaign to reach 250,000 people across various schools and residential areas. Aptivate serves as an ayurvedic appetite stimulant for children, designed to help parents encourage healthy eating patterns. The product is a fundamental component of LupinLife’s initiatives, including the Aptivate Achi Bhookh Fest, which promotes optimal nutrition and strong immunity in children.
Which Key Industry Participants Are Active In The Appetite Stimulant Market?
Major companies operating in the appetite stimulant market are Bristol Myers Squibb, Novartis AG, Solvay Pharmaceuticals, Lupin Limited, TIL Healthcare Private Limited, Zeon Lifesciences Limited, Apex Laboratories Private Limited, Nuray Chemicals Private Limited, Arlak Biotech Private Limited, AdvaCare Pharma USA LLC, Dwarkesh Pharmaceuticals Private Limited, Par Pharmaceutical Companies Inc., Salvus Healthcare Private Limited, Epitome Pharmaceuticals Private Limited, Abiba Pharmacia Private Limited, Pharmika India Private Limited, Wellona Pharma, SiNi Pharma, Vibcare Pharma Private Limited, Mayons Pharmaceuticals Private Limited
Read the full appetite stimulant market report here:
https://www.thebusinessresearchcompany.com/report/appetite-stimulant-global-market-report
Which Region Is Expected To Register The Fastest Growth In The Appetite Stimulant Market?
North America was the largest region in the appetite stimulant market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the appetite stimulant market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Appetite Stimulant Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24149&type=smp
Browse Through More Reports Similar to the Global Appetite Stimulant Market 2026, By The Business Research Company
Weight Loss Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/weight-loss-drugs-global-market-report
Gastrointestinal Drugs Market 2026
https://www.thebusinessresearchcompany.com/report/gastrointestinal-drugs-global-market
Metabolic Disorders Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model